MedPath

Multicenter observational study on imaging classification of drug-related osteonecrosis of the jaw (MRONJ)

Not Applicable
Conditions
Medication-related Osteonecrosis of the Jaws
Registration Number
JPRN-UMIN000048655
Lead Sponsor
agasaki University
Brief Summary

Imaging of MRONJ was investigated in a multicenter study. Periosteal reactions were found in 34.1% (265/777). This was considered a possible indicator of treatment. In addition, 3.5% (27/777) of cases were diagnosed as MRONJ even though there was no osteolysis on CT. The appropriate treatment and outcome of each type, as well as imaging modalities other than CT, such as MRI and scintigraphy, will be discussed in the future.

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
777
Inclusion Criteria

Not provided

Exclusion Criteria

Patients undergoing conebeam CT scan only

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath